Warby Parker Inc. (WRBY) Stock
WRBY has an Alpha Score of 17 out of 100 (poor), computed on Nov 5, 2026 from 3 of 4 sub-scores. 5 of the hedge funds AlphaScala tracks reported WRBY in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Millennium Management's at $25.15M. Company insiders reported 0 open-market buys and 2 sales on SEC Form 4 in the 90 days to Nov 9, 2026. Its trailing P/E ratio is 393.5 and its net margin 0.9% (key statistics as of Nov 5, 2026).
What is WRBY's Alpha Score?
How it works →Alpha Score of 17 reflects poor overall profile with poor momentum, poor value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Computed from 3 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Nov 5, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which hedge funds own WRBY?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Millennium Management Israel Englander | 829K | $25.15M | +57% |
| Atreides Management Gavin Baker | 699K | $21.20M | +2% |
| Point72 Steve Cohen | 336K | $10.20M | +648% |
| Citadel Ken Griffin | 334K | $10.14M | -41% |
| Renaissance Technologies Jim Simons (founder) | 209K | $6.35M | -62% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Warby Parker Inc. insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 1, 26 | Blumenthal Neil Harris | Co-Chief Executive Officer | SELL | 100.0K | $2.8M |
| Oct 1, 26 | Raider Jeffrey Jacob | Director | SELL | 15.0K | $416K |
SEC Form 4 filings as of Nov 9, 2026
See cluster-buy signals across all tickers →What are WRBY's key statistics?
Key statistics as of Nov 5, 2026
How does WRBY's valuation compare with the Healthcare sector?
| Metric | WRBY | Healthcare median | Companies in median |
|---|---|---|---|
| P/E ratio | 393.5 | 29.7 | 114 |
| Net margin | 0.85% | 3.62% | 174 |
| Return on equity | 2.06% | 2.96% | 200 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 10, 2026). P/E excludes loss-making companies.
WRBY price chart
Powered by TradingViewWhat does Warby Parker Inc. do?
Warby Parker Inc. is an American eyeglass retailer known for its commitment to offering stylish, affordable eyewear both online and through physical locations. Founded in 2010, Warby Parker disrupted the eyewear industry by cutting out middlemen, allowing them to sell prescription glasses at a fraction of the traditional cost. Their primary function is to provide consumers with a direct-to-consumer model that emphasizes convenience, with customers able to try on frames at home before purchasing. Warby Parker also extends its reach into the contact lenses and sunglasses markets, catering to a broad range of vision needs. The company is influential in the retail and fashion sectors, particularly within the e-commerce landscape for personal accessories. Leveraging a strong online presence alongside a growing network of brick-and-mortar stores, Warby Parker plays a significant role in how consumers purchase glasses, exemplifying a modern blend of digital and physical retail strategies. Additionally, the company's social mission includes distributing eyewear to those in need worldwide, enhancing its reputation and impact in the global market.